Loading...
Statistics
Advertisement

Lucentis® (ranibizumab injection) for Wet AMD, Diabetic Macular Edema ...
www.eyeonvegfa.us/
Find information and data for healthcare professionals about LUCENTIS® (ranibizumab injection) for the rapid and sustained improvement in vision for the ...

Eyeonvegfa.us

Domain is redirected to: Lucentis.com
Advertisement
Conversion Technology Metas Server
Eyeonvegfa.us is hosted in United States / San Francisco . Eyeonvegfa.us uses HTTPS protocol. Number of used technologies: 3. First technologies: CSS, Html, Javascript, Number of used javascripts: 5. First javascripts: Jquery-1.7.2.min.js, Lib.js, Script.js, Number of used analytics tools: 3. First analytics tools: Google Analytics, Omniture, SiteCatalyst, Its server type is: BigIP.

Technologies in use by Eyeonvegfa.us

Technology

Number of occurences: 3
  • CSS
  • Html
  • Javascript

Advertisement

Javascripts

Number of occurences: 5
  • jquery-1.7.2.min.js
  • lib.js
  • script.js
  • s_code.js
  • omni-handler.js

Analytics

Number of occurences: 3
  • Google Analytics
  • Omniture
  • SiteCatalyst

Server Type

  • BigIP

Powered by

  • Servlet 2.5; JBoss-5.0/JBossWeb-2.1

Conversion rate optimization
visitors Clickable call number Not founded!
visitors Conversion form (contact form, subcriber) Not founded!
visitors Clickable email Not founded!
visitors CTA (call to action) button Not founded!
visitors List Founded!
visitors Image Not founded!
visitors Enhancement Not founded!
visitors Responsive website Founded!
visitors Facebook sharing Not founded!
visitors Google+ sharing Not founded!
visitors Twitter sharing Not founded!
visitors Linkedin sharing Not founded!
visitors Blog on the webiste Not founded!

HTTPS (SSL) - Eyeonvegfa.us

SSL certificate

    • name: /C=US/ST=California/L=South San Francisco/O=Genentech, Inc./CN=*.gene.com
    • subject:
      • C: US
      • ST: California
      • L: South San Francisco
      • O: Genentech, Inc.
      • CN: *.gene.com
    • hash: 73b483ae
    • issuer:
      • C: US
      • O: GeoTrust Inc.
      • CN: GeoTrust SSL CA - G3
    • version: 2
    • serialNumber: 63134964776156801746412813207137807425
    • validFrom: 150514000000Z
    • validTo: 180410235959Z
    • validFrom_time_t: 1431561600
    • validTo_time_t: 1523404799
    • extensions:
      • subjectAltName: DNS:*.gene.com, DNS:gene.com
      • basicConstraints: CA:FALSE
      • keyUsage: Digital Signature, Key Encipherment
      • crlDistributionPoints: Full Name: URI:http://gn.symcb.com/gn.crl
      • certificatePolicies: Policy: 2.23.140.1.2.2 CPS: https://www.geotrust.com/resources/repository/legal User Notice: Explicit Text: https://www.geotrust.com/resources/repository/legal
      • extendedKeyUsage: TLS Web Server Authentication, TLS Web Client Authentication
      • authorityKeyIdentifier: keyid:D2:6F:F7:96:F4:85:3F:72:3C:30:7D:23:DA:85:78:9B:A3:7C:5A:7C
      • authorityInfoAccess: OCSP - URI:http://gn.symcd.com CA Issuers - URI:http://gn.symcb.com/gn.crt

Meta - Eyeonvegfa.us

Number of occurences: 4
  • Name:
    Content: -1
  • Name: description
    Content: Find information and data for healthcare professionals about LUCENTIS® (ranibizumab injection) for the rapid and sustained improvement in vision for the treatment of wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. INDICATION LUCENTIS® (ranibizumab injection) is indicated for the treatment of patients with: -Neovascular (wet) age-related macular degeneration (wAMD) -Macular edema following retinal vein occlusion (RVO) -Diabetic macular edema (DME) IMPORTANT SAFETY INFORMATION LUCENTIS is contraindicated in patients with ocular or periocular infections or hypersensitivity to ranibizumab or any of the excipients in LUCENTIS. WARNINGS AND PRECAUTIONS Intravitreal injections, including those with LUCENTIS, have been associated with endophthalmitis and retinal detachment. Proper aseptic injection technique should always be utilized when administering LUCENTIS. Patients should be monitored during the week following the injection to permit early treatment, should an infection occur. Increases in intraocular pressure (IOP) have been noted within 60 minutes of intravitreal injection. IOP and perfusion of the optic nerve head should be monitored and managed appropriately. Although there was a low rate of arterial thromboembolic events (ATEs) observed in the LUCENTIS clinical trials, there is a potential risk of ATEs following intravitreal use of VEGF inhibitors. ATEs are defined as nonfatal stroke, nonfatal myocardial infarction, or vascular death (including deaths of unknown cause). Neovascular (wet) age-related macular degeneration The ATE rate in the 3 controlled neovascular AMD studies during the first year was 1.9% (17 of 874) in the combined group of patients treated with 0.3 mg or 0.5 mg LUCENTIS compared with 1.1% (5 of 441) in patients from the control arms. In the second year of Studies AMD-1 and AMD-2, the ATE rate was 2.6% (19 of 721) in the combined group of LUCENTIS-treated patients compared with 2.9% (10 of 344) in patients from the control arms. In a pooled analysis of 2-year controlled studies (AMD-1, AMD-2, and a study of LUCENTIS used adjunctively with verteporfin photodynamic therapy), the stroke rate (including both ischemic and hemorrhagic stroke) was 2.7% (13 of 484) in patients treated with 0.5 mg LUCENTIS compared to 1.1% (5 of 435) in patients in the control arms (odds ratio 2.2 [95% confidence interval (0.8-7.1)]). Macular edema following retinal vein occlusion The ATE rate in the 2 controlled RVO studies during the first 6 months was 0.8% in both the LUCENTIS and control arms of the studies (4 of 525 in the combined group of patients treated with 0.3 mg or 0.5 mg LUCENTIS and 2 of 260 in the control arms). The stroke rate was 0.2% (1 of 525) in the combined group of LUCENTIS-treated patients compared to 0.4% (1 of 260) in the control arms. Diabetic macular edema In a pooled analysis of Studies DME-1 and DME-2, the ATE rate at 2 years was 7.2% (18 of 250) with 0.5 mg LUCENTIS, 5.6% (14 of 250) with 0.3 mg LUCENTIS, and 5.2% (13 of 250) with control. The stroke rate at 2 years was 3.2% (8 of 250) with 0.5 mg LUCENTIS, 1.2% (3 of 250) with 0.3 mg LUCENTIS, and 1.6% (4 of 250) with control. At 3 years, the ATE rate was 10.4% (26 of 249) with 0.5 mg LUCENTIS and 10.8% (27 of 250) with 0.3 mg LUCENTIS; the stroke rate was 4.8% (12 of 249) with 0.5 mg LUCENTIS and 2.0% (5 of 250) with 0.3 mg LUCENTIS. A pooled analysis of Studies DME-1 and DME-2 showed that fatalities in the first 2 years occurred in 4.4% (11 of 250) of patients treated with 0.5 mg LUCENTIS, in 2.8% (7 of 250) of patients treated with 0.3 mg LUCENTIS, and in 1.2% (3 of 250) of control patients. Over 3 years, fatalities occurred in 6.4% (16 of 249) of patients treated with 0.5 mg LUCENTIS and in 4.4% (11 of 250) of patients treated with 0.3 mg LUCENTIS. Although the rate of fatal events was low and included causes of death typical of patients with advanced diabetic complications, a potential relationship between these events and intravitreal use of VEGF inhibitors cannot be excluded. ADVERSE EVENTS Serious adverse events related to the injection procedure that occurred in
  • Name: keywords
    Content: Lucentis, ranibizumab, wet amd treatment, wet Age-Related macular degeneration treatment, retinal vein occlusion treatment, macular edema, diabetic macular edema, Age-Related macular degeneration
  • Name: viewport
    Content: user-scalable=yes

Server / Hosting

  • IP: 72.34.128.178
  • Latitude: 37.72
  • Longitude: -122.44
  • Country: United States
  • City: San Francisco

Rname

  • dnadns3e.gene.com
  • dnadns2e.gene.com
  • dnadns4e.gene.com

Target

  • postmaster.no.email.please

HTTP Header Response

HTTP/1.0 301 Moved Permanently Location: http://www.eyeonvegfa.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.0 302 Found Location: http://www.lucentis.com/hcp Server: BigIP Connection: close Content-Length: 0 HTTP/1.0 301 Moved Permanently Location: http://www.lucentis.com/hcp/ Server: BigIP Connection: close Content-Length: 0 HTTP/1.1 405 Method Not Allowed Date: Tue, 26 Apr 2016 02:51:42 GMT X-Powered-By: Servlet 2.5; JBoss-5.0/JBossWeb-2.1 Allow: GET Content-Length: 1075 Keep-Alive: timeout=1, max=100 Connection: close Content-Type: text/html;charset=utf-8 Content-Language: en Set-Cookie: BIGipServerws_products_pool=8WmDh66Huq5D9iHBcUhhssE61/YjhHe7CNYFOHmWTpesmxNMIN78B9SmpI0+PiAeYBVqwiAwe4BdqA==; path=/

DNS

host: eyeonvegfa.us
  1. class: IN
  2. ttl: 3597
  3. type: A
  4. ip: 72.34.128.116
host: eyeonvegfa.us
  1. class: IN
  2. ttl: 3600
  3. type: NS
  4. target: dnadns3e.gene.com
host: eyeonvegfa.us
  1. class: IN
  2. ttl: 3600
  3. type: NS
  4. target: dnadns2e.gene.com
host: eyeonvegfa.us
  1. class: IN
  2. ttl: 3600
  3. type: NS
  4. target: dnadns4e.gene.com
host: eyeonvegfa.us
  1. class: IN
  2. ttl: 3600
  3. type: SOA
  4. mname: bc-dns-ext-mstr.gene.com
  5. rname: postmaster.no.email.please
  6. serial: 459944446
  7. refresh: 3600
  8. retry: 600
  9. expire: 2592000
  10. minimum-ttl: 3600

Common Typos/Mistakes

This list shows You some spelling mistakes at internet search for this domain.

www.yeonvegfa.us, www.exyeonvegfa.us, www.xyeonvegfa.us, www.esyeonvegfa.us, www.syeonvegfa.us, www.ewyeonvegfa.us, www.wyeonvegfa.us, www.eryeonvegfa.us, www.ryeonvegfa.us, www.efyeonvegfa.us, www.fyeonvegfa.us, www.evyeonvegfa.us, www.vyeonvegfa.us, www.ecyeonvegfa.us, www.cyeonvegfa.us, www.eqyeonvegfa.us, www.qyeonvegfa.us, www.eayeonvegfa.us, www.ayeonvegfa.us, www.eyyeonvegfa.us, www.yyeonvegfa.us, www.eeonvegfa.us, www.eyzeonvegfa.us, www.ezeonvegfa.us, www.eyaeonvegfa.us, www.eaeonvegfa.us, www.eyseonvegfa.us, www.eseonvegfa.us, www.eydeonvegfa.us, www.edeonvegfa.us, www.eyeonvegfa.us, www.eeonvegfa.us, www.eyceonvegfa.us, www.eceonvegfa.us, www.ey eonvegfa.us, www.e eonvegfa.us, www.eyonvegfa.us, www.eyexonvegfa.us, www.eyxonvegfa.us, www.eyesonvegfa.us, www.eysonvegfa.us, www.eyewonvegfa.us, www.eywonvegfa.us, www.eyeronvegfa.us, www.eyronvegfa.us, www.eyefonvegfa.us, www.eyfonvegfa.us, www.eyevonvegfa.us, www.eyvonvegfa.us, www.eyeconvegfa.us, www.eyconvegfa.us, www.eyeqonvegfa.us, www.eyqonvegfa.us, www.eyeaonvegfa.us, www.eyaonvegfa.us, www.eyeyonvegfa.us, www.eyyonvegfa.us, www.eyenvegfa.us, www.eyeobnvegfa.us, www.eyebnvegfa.us, www.eyeohnvegfa.us, www.eyehnvegfa.us, www.eyeognvegfa.us, www.eyegnvegfa.us, www.eyeojnvegfa.us, www.eyejnvegfa.us, www.eyeomnvegfa.us, www.eyemnvegfa.us, www.eyeo nvegfa.us, www.eye nvegfa.us, www.eyeovnvegfa.us, www.eyevnvegfa.us, www.eyeovegfa.us, www.eyeonnvegfa.us, www.eyeonvegfa.us, www.eyeonhvegfa.us, www.eyeohvegfa.us, www.eyeonjvegfa.us, www.eyeojvegfa.us, www.eyeonkvegfa.us, www.eyeokvegfa.us, www.eyeonlvegfa.us, www.eyeolvegfa.us, www.eyeon vegfa.us, www.eyeo vegfa.us, www.eyeonegfa.us, www.eyeonvyegfa.us, www.eyeonyegfa.us, www.eyeonvzegfa.us, www.eyeonzegfa.us, www.eyeonvhegfa.us, www.eyeonhegfa.us, www.eyeonvnegfa.us, www.eyeonnegfa.us, www.eyeonvmegfa.us, www.eyeonmegfa.us, www.eyeonvjegfa.us, www.eyeonjegfa.us, www.eyeonvkegfa.us, www.eyeonkegfa.us, www.eyeonviegfa.us, www.eyeoniegfa.us, www.eyeonvgfa.us, www.eyeonvexgfa.us, www.eyeonvxgfa.us, www.eyeonvesgfa.us, www.eyeonvsgfa.us, www.eyeonvewgfa.us, www.eyeonvwgfa.us, www.eyeonvergfa.us, www.eyeonvrgfa.us, www.eyeonvefgfa.us, www.eyeonvfgfa.us, www.eyeonvevgfa.us, www.eyeonvvgfa.us, www.eyeonvecgfa.us, www.eyeonvcgfa.us, www.eyeonveqgfa.us, www.eyeonvqgfa.us, www.eyeonveagfa.us, www.eyeonvagfa.us, www.eyeonveygfa.us, www.eyeonvygfa.us, www.eyeonvefa.us, www.eyeonvegsfa.us, www.eyeonvesfa.us, www.eyeonvegxfa.us, www.eyeonvexfa.us, www.eyeonvegyfa.us, www.eyeonveyfa.us, www.eyeonveghfa.us, www.eyeonvehfa.us, www.eyeonvegnfa.us, www.eyeonvenfa.us, www.eyeonvegcfa.us, www.eyeonvecfa.us, www.eyeonvegdfa.us, www.eyeonvedfa.us, www.eyeonvegefa.us, www.eyeonveefa.us, www.eyeonvegrfa.us, www.eyeonverfa.us, www.eyeonvegtfa.us, www.eyeonvetfa.us, www.eyeonvegbfa.us, www.eyeonvebfa.us, www.eyeonvegvfa.us, www.eyeonvevfa.us, www.eyeonvega.us, www.eyeonvegfqa.us, www.eyeonvegqa.us, www.eyeonvegfa.us, www.eyeonvega.us, www.eyeonvegfaa.us, www.eyeonvegaa.us, www.eyeonvegfya.us, www.eyeonvegya.us, www.eyeonvegfta.us, www.eyeonvegta.us, www.eyeonvegfga.us, www.eyeonvegga.us, www.eyeonvegfba.us, www.eyeonvegba.us, www.eyeonvegfwa.us, www.eyeonvegwa.us, www.eyeonvegfsa.us, www.eyeonvegsa.us, www.eyeonvegfda.us, www.eyeonvegda.us, www.eyeonvegfra.us, www.eyeonvegra.us, www.eyeonvegf3a.us, www.eyeonveg3a.us, www.eyeonvegf4a.us, www.eyeonveg4a.us,

Other websites we recently analyzed

  1. vaughanenokian.net
    United States - 208.91.197.27
    Server software: Apache
    Technology: Html
    Number of meta tags: 2
  2. Go And Thrive
    Scottsdale (United States) - 160.153.35.8
    Server software: Apache/2.4.23
    Technology: CSS, Font Awesome, Google Font API, Html, Html5, Javascript, jQuery, Php, Pingback, SVG, Wordpress
    Number of Javascript: 14
    Number of meta tags: 3
  3. Family Therapy | Life Coaching | Barrie | Alliston | Collingwood
    The Trusted place to go for Family Therapy & Life Coaching in Barrie, Alliston and Collingwood.
    Saint-quentin (Canada) - 72.10.165.220
    Server software: Apache
    Technology: BootstrapCDN, Maxcdn, CSS, Flexslider, Font Awesome, Html, Html5, Javascript, jQuery, Php, W3 Total cache, Google Analytics, Wordpress, Facebook Box, Linkedin Share button, Twitter Button
    Number of Javascript: 26
    Number of meta tags: 5
  4. pkgl.site
    China - 124.16.31.156
    Server software: Tengine/1.4.2
    Technology: CloudFront, Google Adsense, Html, Javascript, Php
    Number of Javascript: 2
    Number of meta tags: 1
  5. Tauchmedizin Linz
    Tauchmedizin Linz - Dr. Hedwig Bostl-Scheuringer
    Austria - 86.59.107.231
    Server software: Apache/2.2.16 (Debian) PHP/5.3.3-7+squeeze14 with Suhosin-Patch mod_python/3.3.1 Python/2.6.6 mod_ruby/1.2.6 Ruby/1.8.7(2010-08-16) mod_perl/2.0.4 Perl/v5.10.1
    Technology: CSS, Html, Javascript
    Number of meta tags: 4
  6. HealthCAWS
    HealthCAWS provides technology solutions and thought leadership on consumer and provider engagement, accountability and support tools, and outcomes.
    Houston (United States) - 108.167.135.116
    Server software: Apache-Coyote/1.1
    Technology: CSS, Google Font API, Html, Html5, Javascript
    Number of Javascript: 4
    Number of meta tags: 3
  7. Olympias SA | European Transports and Logistics
    Ashburn (United States) - 54.174.211.229
    Server software: Apache/2.2.14 (Ubuntu)
    Technology: CSS, Html, Html5, Javascript, Wix
    Number of Javascript: 2
    Number of meta tags: 5
  8. Eurd.de
    Germany - 88.198.231.2
    Server software: Apache/2.4.10 (Debian)
    Technology: CSS, Html, Html5, Javascript, jQuery
    Number of Javascript: 15
    Number of meta tags: 4
  9. thecareersboutique.com
    Ireland - 78.153.212.173
    Server software: Apache/2.2.11 (Unix) FrontPage/5.0.2.2635
    Technology: CSS, Html, Javascript, Php
    Number of meta tags: 2
  10. BIWISER |
    Santiago (Chile) - 201.148.104.102
    G Analytics ID: UA-76799056-1
    Server software: Apache
    Technology: CSS, Html, Html5, Iframe, Javascript, jQuery, MediaElement, Php, Pingback, Shortcodes, Schema.org, SVG, Google Analytics, Wordpress
    Number of Javascript: 13
    Number of meta tags: 4

Check Other Websites